Introduction

Lockton’s People Solutions Market Update offers comprehensive quarterly insights on the U.S. market and industry dynamics impacting cost management, employee wellbeing, and benefits strategies. In this Q3 2025 edition, we explore rising medical and pharmacy cost projections emerging from Lockton’s 2025 Trend Study.


Contents

Q3 snapshot

Healthcare costs will remain higher than historical norms

Continue reading

Cost projections are higher than expected, with little relief in sight

Healthcare trend reached 8.1% in 2024

Continue reading

Pharmacy challenges grow in a complex environment

Pharmacy dynamics continue to intensify

Continue reading

Medical stop loss sees a volatile, tightening market

High-cost claims are exceeding deductibles at a growing rate

Continue reading

Global trends reflect continued high costs

Rising costs aren't isolated to the U.S.

Continue reading

Contributors

Shannon Demaree, ASA, MAAA, FCA

EVP, Regional Executive, People Solutions

Jason D'Ambrosio, FSA, MAAA

Actuary

Shealynn Buck, MD

Chief Medical Officer

Nicholas Dobelbower

SVP, Global People Solutions

Todd Hlasney, CEBS, FPA, GBA

SVP, Precision Health Practice

Robert Kordella, RPh

Chief Clinical Officer, Pharmacy Analytics

Shelly Lewis

VP, Director of Actuarial Analytics

Slayton Rous

VP, Growth and Strategy, Stop Loss

Jenae Johnson

Content Strategist, People Solutions

Q2 2025 Market Update recap

With benefit plan costs continuing to rise, as seen in our Q1 Market Update data, plan sponsors are under growing pressure to make plan changes. In the Q2 2025 edition, we explored how employers are responding to the pressured, uncertain landscape and rising costs, based on results from Lockton’s 2025 National Benefits Survey and 2025 Workforce Priorities Survey.

Read the Q2 update

© 2025 Lockton Companies. All rights reserved.

Up Next: Q3 snapshot

Next page

Page Name

Back Page

© 2024 Lockton Companies. All rights reserved.

Page Name

Next Page